| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |